Literature DB >> 33622770

Behavioral Battery for Testing Candidate Analgesics in Mice. I. Validation with Positive and Negative Controls.

C M Diester1, E J Santos1, M J Moerke1, S S Negus2.   

Abstract

This study evaluated a battery of pain-stimulated, pain-depressed, and pain-independent behaviors for preclinical pharmacological assessment of candidate analgesics in mice. Intraperitoneal injection of dilute lactic acid (IP acid) served as an acute visceral noxious stimulus to produce four pain-related behaviors in male and female ICR mice: stimulation of 1) stretching, 2) facial grimace, 3) depression of rearing, and 4) depression of nesting. Additionally, nesting and locomotion in the absence of the noxious stimulus were used to assess pain-independent drug effects. These six behaviors were used to compare effects of two mechanistically distinct but clinically effective positive controls (ketoprofen and oxycodone) and two negative controls that are not clinically approved as analgesics but produce either general motor depression (diazepam) or motor stimulation (amphetamine). We predicted that analgesics would alleviate all IP acid effects at doses that did not alter pain-independent behaviors, whereas negative controls would not. Consistent with this prediction, ketoprofen (0.1-32 mg/kg) produced the expected analgesic profile, whereas oxycodone (0.32-3.2 mg/kg) alleviated all IP acid effects except depression of rearing at doses lower than those that altered pain-independent behaviors. For the negative controls, diazepam (1-10 mg/kg) failed to block IP acid-induced depression of either rearing or nesting and only decreased IP acid-stimulated behaviors at doses that also decreased pain-independent behaviors. Amphetamine (0.32-3.2 mg/kg) alleviated all IP acid effects but only at doses that also stimulated locomotion. These results support utility of this model as a framework to evaluate candidate-analgesic effects in a battery of complementary pain-stimulated, pain-depressed, and pain-independent behavioral endpoints. SIGNIFICANCE STATEMENT: Preclinical assays of pain and analgesia often yield false-positive effects with candidate analgesics. This study used two positive-control analgesics (ketoprofen, oxycodone) and two active negative controls (diazepam, amphetamine) to validate a strategy for distinguishing analgesics from nonanalgesics by profiling drug effects in a battery of complementary pain-stimulated, pain-depressed, and pain-independent behaviors in male and female mice.
Copyright © 2021 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33622770      PMCID: PMC8058504          DOI: 10.1124/jpet.120.000464

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  65 in total

Review 1.  Animal models of nociception.

Authors:  D Le Bars; M Gozariu; S W Cadden
Journal:  Pharmacol Rev       Date:  2001-12       Impact factor: 25.468

2.  Why patients visit their doctors: assessing the most prevalent conditions in a defined American population.

Authors:  Jennifer L St Sauver; David O Warner; Barbara P Yawn; Debra J Jacobson; Michaela E McGree; Joshua J Pankratz; L Joseph Melton; Véronique L Roger; Jon O Ebbert; Walter A Rocca
Journal:  Mayo Clin Proc       Date:  2013-01       Impact factor: 7.616

Review 3.  Inflammatory and Neuropathic Pain From Bench to Bedside: What Went Wrong?

Authors:  Robert P Yezierski; Per Hansson
Journal:  J Pain       Date:  2018-01-04       Impact factor: 5.820

4.  Inflammation-induced reduction of spontaneous activity by adjuvant: A novel model to study the effect of analgesics in rats.

Authors:  David J Matson; Daniel C Broom; Susan R Carson; James Baldassari; John Kehne; Daniel N Cortright
Journal:  J Pharmacol Exp Ther       Date:  2006-10-18       Impact factor: 4.030

5.  Analgesic activities of amphetamine isomers.

Authors:  D R Tocco; R P Maickel
Journal:  Arch Int Pharmacodyn Ther       Date:  1984-03

6.  Involvement of neuropeptide FF receptors in neuroadaptive responses to acute and chronic opiate treatments.

Authors:  K Elhabazi; J M Trigo; C Mollereau; L Moulédous; J-M Zajac; F Bihel; M Schmitt; J J Bourguignon; H Meziane; B Petit-demoulière; F Bockel; R Maldonado; F Simonin
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

7.  Using Cageside Measures to Evaluate Analgesic Efficacy in Mice (Mus musculus) after Surgery.

Authors:  Vanessa L Oliver; Sarah E Thurston; Jennifer L Lofgren
Journal:  J Am Assoc Lab Anim Sci       Date:  2018-03-01       Impact factor: 1.232

8.  Antinociceptive profiles of non-peptidergic neurokinin1 and neurokinin2 receptor antagonists: a comparison to other classes of antinociceptive agent.

Authors:  L Seguin; S Le Marouille-Girardon; M J Millan
Journal:  Pain       Date:  1995-05       Impact factor: 6.961

9.  Experimental design and analysis for consideration of sex as a biological variable.

Authors:  Clare M Diester; Matthew L Banks; Gretchen N Neigh; S Stevens Negus
Journal:  Neuropsychopharmacology       Date:  2019-07-05       Impact factor: 7.853

10.  "Bedside-to-Bench" Behavioral Outcomes in Animal Models of Pain: Beyond the Evaluation of Reflexes.

Authors:  Enrique J Cobos; Enrique Portillo-Salido
Journal:  Curr Neuropharmacol       Date:  2013-12       Impact factor: 7.363

View more
  5 in total

1.  Opioid-like adverse effects of tianeptine in male rats and mice.

Authors:  T R Baird; H I Akbarali; W L Dewey; H Elder; M Kang; S A Marsh; M R Peace; J L Poklis; E J Santos; S S Negus
Journal:  Psychopharmacology (Berl)       Date:  2022-02-24       Impact factor: 4.530

2.  Novel bivalent ligands carrying potential antinociceptive effects by targeting putative mu opioid receptor and chemokine receptor CXCR4 heterodimers.

Authors:  Hongguang Ma; Mengchu Li; Piyusha P Pagare; Huiqun Wang; Nima Nassehi; Edna J Santos; S Stevens Negus; Dana E Selley; Yan Zhang
Journal:  Bioorg Chem       Date:  2022-01-24       Impact factor: 5.307

3.  Effects of Ketoprofen and Morphine on Pain-Related Depression of Nestlet Shredding in Male and Female Mice.

Authors:  Jamani B Garner; Laura S Marshall; Nathaniel M Boyer; Vinaya Alapatt; Laurence L Miller
Journal:  Front Pain Res (Lausanne)       Date:  2021-06-08

4.  Morphine Exacerbates Experimental Colitis-Induced Depression of Nesting in Mice.

Authors:  Stanley M Cheatham; Karan H Muchhala; Eda Koseli; Joanna C Jacob; Essie Komla; S Stevens Negus; Hamid I Akbarali
Journal:  Front Pain Res (Lausanne)       Date:  2021-12-13

5.  Behavioral Battery for Testing Candidate Analgesics in Mice. II. Effects of Endocannabinoid Catabolic Enzyme Inhibitors and ∆9-Tetrahydrocannabinol.

Authors:  C M Diester; A H Lichtman; S S Negus
Journal:  J Pharmacol Exp Ther       Date:  2021-02-23       Impact factor: 4.030

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.